Start date
13/03/2024
On March 13, 2024, DOWRAB, a rabies vaccine developed by Dow University of Health Sciences, was officially launched, marking a significant milestone. The ceremony, attended by the Honorable Vice Chancellor, Prof. Mohammed Saeed Quraishy T.I., marked the start of a new era in the fight against rabies.
The occasion, attended by our marketing and distribution partner Muller and Phipps (M&P), and esteemed leadership and marketing team, reflected a common commitment to public health and welfare.
DOWRAB’s availability extends our commitment to social and community service across Pakistan, to drastically reduce the incidence of rabies cases.
